Sana Kliniken AG

Hospital


Location: Ismaning (head quarters), Germany (DE) DE

ISNI: 000000405583380


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Laparoscopic right hemicolectomy with CME: standardization using the "critical view" concept (2018) Strey CW, Wullstein C, Adamina M, Agha A, Aselmann H, Becker T, Grützmann R, et al. Journal article IL-23 is centrally involved in mediating molecular resistance to anti-TNF therapy in Crohn's disease patients (2018) Schmitt H, Billmeier U, Dieterich W, Rath T, Sonnewald S, Reid S, Hirschmann S, et al. Conference contribution Treatment of diabetes in old age — individualisation mandatory! 5 Faustregeln für die Behandlung betagter Diabetiker (2017) Zeeh J, Zeyfang A, Heppner HJ Journal article, Review article Antibacterial Effect of a 4x Cu-TiO2 Coating Simulating Acute Periprosthetic Infection-An Animal Model (2017) Mauerer A, Stenglein S, Schulz-Drost S, Schoerner C, Taylor D, Krinner S, Heidenau F, et al. Journal article Efficacy and safety of Hybrid-APC for the ablation of Barrett’s esophagus (2016) Manner H, May A, Kouti I, Pech O, Vieth M, Ell C Journal article Erratum to: Efficacy and safety of Hybrid-APC for the ablation of Barrett’s esophagus (Surg Endosc, DOI 10.1007/s00464-015-4336-1) (2016) Manner H, May A, Kouti I, Pech O, Vieth M, Ell C Journal article, Erratum Randomized, open-label, phase II study comparing the efficacy and the safety of cabazitaxel versus weekly paclitaxel given as neoadjuvant treatment in patients with operable triple negative or luminal B/HER2 normal breast cancer (GENEVIEVE) (2016) Paepke S, Huober J, Sherko K, Eidtmann H, Untch M, Costa SD, Blohmer JU, et al. Conference contribution Zoledronate for patients with invasive residual disease after anthracyclines-taxane-based chemotherapy for early breast cancer - The Phase III NeoAdjuvant Trial Add-oN (NaTaN) study (GBG 36/ABCSG 29) (2016) Von Minckwitz G, Rezai M, Tesch H, Huober J, Gerber B, Zahm DM, Hilfrich J, et al. Journal article Biosimilars in inflammatory bowel disease (2016) Siegmund B, Atreya R, Bokemeyer B, Kruis W, Mudter J, Sander C, Schreiber S, et al. Journal article Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases (2016) De With K, Allerberger F, Amann S, Apfalter P, Brodt HR, Eckmanns T, Fellhauer M, et al. Journal article